Dauntless Investment Group »

C4 Therapeutics shares owned by Dauntless Investment Group

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Dauntless Investment Group from 13F filings

Historical chart of Dauntless Investment Group investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Dauntless Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Dauntless Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $40k 15k 2.63

More positions owned by Dauntless Investment Group

Ishares Tr 7-10 Yr Trsy Bd Call Option (IEF)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)
Select Sector Spdr Tr State Street Con Put Option (XLY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
Ishares Tr China Lg-cap Etf Call Option (FXI)
Innoviva (INVA)
Femasys (FEMY)
Tiziana Life Sciences Common Shares (TLSA)
Aeon Biopharma Cl A New (AEON)
Lincoln Educational Services Corporation (LINC)
Coursera (COUR)
St. Joe Company (JOE)
Profound Med Corp Com New (PROF)
Oncology Institu (TOI)

View all positions for Dauntless Investment Group

Top funds holding C4 Therapeutics

Morgan Stanley
RA Capital Management
Bain Capital Life Sciences Investors
Lynx1 Capital Management
Vanguard Capital Management
Soleus Capital Management
Daniel D. Thurber
Two Sigma Investments
Citadel Advisors
Renaissance Technologies
Goldman Sachs Group
Bank of America Corporation
Squadron Capital Management
BlackRock
Silverarc Capital Management

View all funds holding C4 Therapeutics